Mylan Donates One Millionth Free Epinephrine Auto-Injector through EpiPen4Schools® Program

Mylan recently announced its EpiPen4Schools® program has donated more than one million epinephrine auto-injectors to schools across the United States. Epinephrine is the only first-line treatment for anaphylaxis, which can occur quickly and without warning. As more than 1,500 anaphylactic events were reported in the 2015-2016 school year, ensuring access to this life-saving medicine in the school setting is critical.

Since the program was launched five years ago, Mylan has worked tirelessly to break down barriers in order to expand access to this life-saving medicine in public and private schools across the country. In 2011, Mylan began working with advocacy groups, parents and legislators to advocate for laws that would permit “undesignated” epinephrine auto-injectors in schools – or where a prescription can be in a school’s name rather than in a child’s name so that any individual experiencing an anaphylactic emergency can have access to the epinephrine auto-injectors. In the years since, as a result of collective efforts of the severe allergy community, the legislative landscape has evolved considerably. Today, stock epinephrine in schools is permitted in 48 states, compared to just eight states in 2010. Only Alaska and Hawaii have yet to pass similar legislation.

Since 2014, donated epinephrine auto-injectors have been used more than 2,000 times to treat anaphylaxis in schools. Mylan has received countless testimonials from patients, schools, healthcare professionals and medical and patient organizations sharing the positive impact of the program.

"We are appreciative of Mylan's EpiPen4Schools program so that we have access to epinephrine auto-injectors in the event of someone on school property experiencing an anaphylactic emergency," said Connie Trent, RN, BSN, Health Services Facilitator, Forsyth County Schools, Cumming, Ga. "In fact, we have used the stock epinephrine auto-injectors provided through the program four times during this school year alone. Some of those being treated had never been previously diagnosed with a potentially life-threatening allergy."

To date, more than half of all schools in the US have participated in the program since launch, a number now exceeding more than 73,000 schools. Today, the top 10 participating states include Nebraska, Connecticut, Nevada, North Carolina, Michigan, New Jersey, Massachusetts, Virginia, Delaware and Utah.

Mylan’s EpiPen4Schools program provides qualifying schools with up to four free epinephrine auto-injectors so they are available in the event a person experiences anaphylaxis in the school setting. Schools can enroll in the program by visiting EpiPen4Schools.com.



Important Safety Information

Use EpiPen® (epinephrine injection, USP) 0.3 mg or EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors right away when you have an allergic emergency (anaphylaxis). Get emergency medical help right away. You may need further medical attention. Only a healthcare professional should give additional doses of epinephrine if you need more than two injections for a single anaphylactic episode. EpiPen® or EpiPen Jr® should only be injected into the middle of your outer thigh (upper leg), through clothing if necessary. Do not inject into your veins, buttocks, fingers, toes, hands or feet. Hold the leg of young children firmly in place before and during injection to prevent injuries. In case of accidental injection, please seek immediate medical treatment.

Rarely, patients who have used EpiPen® or EpiPen Jr® may develop an infection at the injection site within a few days. Some of these infections can be serious. Call your healthcare professional right away if you have any of the following at an injection site: redness that does not go away, swelling, tenderness, or the area feels warm to the touch.

Tell your healthcare professional about all of your medical conditions, especially if you have asthma, a history of depression, thyroid problems, Parkinson’s disease, diabetes, high blood pressure or heart problems, have any other medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Be sure to also tell your healthcare professional all the medicines you take, especially medicines for asthma. If you have certain medical conditions, or take certain medicines, your condition may get worse or you may have longer lasting side effects when you use EpiPen® or EpiPen Jr®.

Common side effects include fast, irregular or “pounding” heartbeat, sweating, nausea or vomiting, breathing problems, paleness, dizziness, weakness, shakiness, headache, feelings of over excitement, nervousness or anxiety. These side effects usually go away quickly if you lie down and rest. Tell your healthcare professional if you have any side effect that bothers you or that does not go away.

Indications

EpiPen® and EpiPen Jr® Auto-Injectors are for the emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers; and for people who are at increased risk for these reactions. EpiPen® and EpiPen Jr® are intended for immediate administration as emergency supportive therapy only. Seek immediate emergency medical help right away.


Please see the full Prescribing Information and Patient Information.

For additional information please contact us at 800-395-3376.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.